TipRanks
Advertisement
Advertisement
Faeth Therapeutics assumed with a Buy at Lucid Capital
PremiumThe FlyFaeth Therapeutics assumed with a Buy at Lucid Capital
27d ago
Faeth Therapeutics initiated with a Buy at TD Cowen
Premium
The Fly
Faeth Therapeutics initiated with a Buy at TD Cowen
1M ago
Faeth Therapeutics announces inducement grants under Nasdaq listing rule
Premium
The Fly
Faeth Therapeutics announces inducement grants under Nasdaq listing rule
1M ago
Analyst Reiterates Buy on Faeth, Maintains $60 Price Target Ahead of Phase 2 Readouts
PremiumRatingsAnalyst Reiterates Buy on Faeth, Maintains $60 Price Target Ahead of Phase 2 Readouts
2M ago
BTIG Reiterates Buy on PIKTOR as New PK/PD Data De-Risk Development and Support Unchanged $55 Price Target
Premium
Ratings
BTIG Reiterates Buy on PIKTOR as New PK/PD Data De-Risk Development and Support Unchanged $55 Price Target
2M ago
Faeth Therapeutics: Buy Rating Reiterated as PIKTOR Advances in Key Oncology Trials; $60 Price Target Maintained
Premium
Ratings
Faeth Therapeutics: Buy Rating Reiterated as PIKTOR Advances in Key Oncology Trials; $60 Price Target Maintained
2M ago
Faeth Therapeutics initiated with an Outperform at Raymond James
PremiumThe FlyFaeth Therapeutics initiated with an Outperform at Raymond James
2M ago
Faeth Therapeutics initiated with an Outperform at Oppenheimer
Premium
The Fly
Faeth Therapeutics initiated with an Outperform at Oppenheimer
3M ago
Faeth Therapeutics Adopts Performance-Based Stock Option Plan
Premium
Company Announcements
Faeth Therapeutics Adopts Performance-Based Stock Option Plan
3M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―